Uniphore Acquiring ActionIQ and Infoworks to Deliver the Industry’s First Zero Data AI Cloud
5.12.2024 11:57:00 CET | Business Wire | Press release
Strategic acquisitions unleash Enterprise data to create knowledge, fine tune AI models, create powerful AI agents and drive business transformation.
Uniphore, the global leader in Enterprise AI, today announced it is acquiring two industry-leading data powerhouses, ActionIQ and Infoworks, which significantly expands its AI-powered offerings. These strategic acquisitions extend Uniphore’s comprehensive end-to-end Enterprise AI platform and will deliver the industry’s first Zero Data AI Cloud.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205133623/en/

Uniphore is acquiring two industry-leading data powerhouses, ActionIQ and Infoworks, which significantly expands its AI-powered offerings. These strategic acquisitions extend Uniphore’s comprehensive end-to-end Enterprise AI platform and will deliver the industry’s first Zero Data AI Cloud. (Graphic: Business Wire)
A Zero Data AI Cloud enables enterprises to overcome the largest barriers of AI adoption – data access, accuracy, flexibility and data sovereignty. It removes data bottlenecks and delivers powerful AI capabilities while preserving customers’ existing data landscape and avoids complex integration challenges. Uniphore’s Zero Data AI Cloud is built on an infrastructure-agnostic architecture that creates a seamless data fabric across any data platform, enterprise application, or cloud environment.
By bringing Uniphore, ActionIQ and Infoworks together, enterprise customers will have access to an entire suite of AI capabilities that empowers organizations to move beyond proof-of-concept AI trials into full scale implementation, accelerating their digital transformation.
In addition to their industry-leading customer data solutions, ActionIQ brings their Composable Zero-copy Data Platform, which enables enterprises to connect all data, from anywhere, and make it AI-ready without requiring any long integration or ETL projects. Infoworks brings their Enterprise Data Platform which includes intelligent AI data agents that can discover, identify, organize, catalogue and clean enterprise data with little human supervision.
Their combined expertise and innovative technology enable enterprises to leverage all their data for AI initiatives without the need to move, transform, or copy it, and will accelerate the time to achieve results down to weeks, not years, all while maintaining high standards of governance and security.
“This is a defining moment for Enterprise AI,” said Umesh Sachdev, CEO and co-founder of Uniphore. “With the acquisitions of ActionIQ and Infoworks, Uniphore is enabling a Zero Data AI Cloud for the world’s largest companies, equipping them with the tools to fast-track AI deployments and drive measurable business outcomes.”
Tasso Argyros, CEO and co-founder of ActionIQ said, "At ActionIQ we’ve been hyper-focused on data and helped create and now lead the massive category of Customer Data Platforms, helping dozens of F1000 enterprises transform their Customer Experience. It is my belief that the future of CDPs is AI and CX Agents. Bringing together Uniphore's industry-leading AI capabilities and ActionIQ's data and CX capabilities will allow us to continue leading the market and deliver world class solutions to the world.”
"Data has long been a challenge for enterprises to modernize their operations and embracing AI innovations," said Amar Arsikere, Founder at Infoworks. "At Infoworks, we are redefining data engineering with groundbreaking automation that seamlessly handles every data task for any kind of data. By joining forces with Uniphore, we now deliver a comprehensive Data + AI solution that accelerates the development of Enterprise AI applications and empowers organizations to unlock their full potential."
Powering Business Transformation with a Zero Data AI Cloud
Uniphore is pioneering a revolutionary approach leveraging a multi-layered AI architecture comprised of a composable data layer, knowledge layer, model layer and agentic layer. Within each layer, Uniphore has feature-rich solutions, with continued investments planned in each area.
- Composable Data Layer
Organizations can instantly harness their enterprise data without complex migrations or copies. Enterprises can maintain complete control of their data assets across global operations. It reduces AI deployment time from months to weeks.
- Knowledge Layer
Enterprise data is transformed into an AI-ready knowledge lake. It ensures that AI outputs are grounded in an organization’s business reality without hallucinations. This allows organizations to fully leverage and protect their institutional knowledge and experience.
- Model Layer
All the capabilities in this layer enable countless options for enterprises to easily pick relevant foundational models and/or work with multiple models to meet their business needs. Within the model layer there are also tooling capabilities to easily create fine-tuned industry and enterprise specific small language models.
- Agentic Layer
This is where digital transformation is accelerated with ready-to-deploy AI agents across core functions such as customer service, marketing, HR, sales, and more. Further, this layer empowers the functional user and citizen developer to build and manage intelligent and personalized AI agents for specific business needs and workflow automation.
With this unique 4-layer approach, customers now can fully leverage Uniphore’s suite of end-to-end AI capabilities through an open architecture, while ensuring data sovereignty and enterprise-grade scalability. Organizations maintain complete control while deploying AI solutions across any scale—from department level solutions all the way to sophisticated global operations.
Enterprise AI That Delivers Results
Large enterprises are increasingly looking for solutions that enable them to become more agile, responsive, and data-driven in their decision-making. With the acquisition of ActionIQ and Infoworks, Uniphore is the only Enterprise AI company with an end-to-end solution for a Zero Data AI Cloud that delivers:
- Accelerated Time to Value
Now, customers can deploy enterprise-wide AI solutions in weeks, by enabling seamless data access. With support for multi-cloud and virtual private cloud deployments, enterprises’ needs for flexible and secure access to data are achieved. Further, Uniphore delivers enterprises an end-to-end AI stack with pre-built applications today for customer service, sales, HR, marketing, and more as well as the capabilities to build their own intelligent agents.
- Superior AI Performance
High accuracy is now attainable because of fine-tuned industry and enterprise models that access an enterprise’s knowledge in any data format. The Uniphore solution also delivers consistent results aligned with any company’s business context beyond what traditional RAG solutions provide. Because of Uniphore’s open architecture and orchestration capabilities, enterprises can leverage their existing best-in-class solutions, based on business needs, to support multiple models.
- Enterprise Data Freedom
The Uniphore Zero Data AI Cloud enables the use of multi-modal data across any platform, architecture, or application. There no longer needs to be any disruption to existing systems and workflows and no vendor lock-in. This gives customers complete control over sensitive enterprise knowledge and information.
This strategic move from Uniphore cements its leadership position as an Enterprise AI innovator. Uniphore will continue to deliver industry-leading solutions, including expanding the ActionIQ composable CDP solution to capitalize on the multi-billion-dollar CDP market opportunity and will continue to enhance its established portfolio of solutions that currently are in use at some of the world’s largest corporations. The ActionIQ solution is currently listed as a leader in the Forrester Wave competitive report on Customer Data Platforms.
For additional information on these acquisitions, please see our information page, which has a fact sheet on ActionIQ and afact sheet on Infoworks. Tidal Partners LLC acted as exclusive financial advisor to Uniphore on the transaction.
About Uniphore
Uniphore is a leading B2B AI-native company with decades of proven success. Engineered for scalability and tailored for enterprise needs, we drive AI transformation that delivers real business impact across multiple industries and the largest global deployments. Our Zero Data AI Cloud is built on a multimodal AI and data platform and is at the heart of this transformation, enabling businesses to swiftly deploy AI across the enterprise. With our Zero-Data AI Cloud, organizations can harness their data and create scalable, domain-specific AI models to democratize enterprise knowledge—all while ensuring security, sovereignty, and rapid value delivery. Today, Uniphore’s technology empowers over 750,000 end-users across 1,600 enterprises in 20 countries. Discover the unmatched capabilities of Uniphore—because there’s no AI like it™.
For more information about Uniphore’s solutions, visit [www.uniphore.com]
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205133623/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom